Re-Emergence of Minimal Residual Disease Detected by Flow Cytometry Predicts an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia.

The median duration from MRD negativity to MRD re-emergence tended to be shorter for patients who experienced a subsequent relapse, although the differences did not reach statistical significance (11.9 vs. 15.0 months, p = 0.068) ( Figure 3B ).

also in 111,027 other papers